XenoTherapeutics Foundation is a groundbreaking not-for-profit, clinical-stage regenerative medicine company that is at the forefront of developing new biotherapies from genetically engineered animals. With a mission to redefine regenerative medicine, XenoTherapeutics leverages live cell biotherapies derived from genetically altered source animals to facilitate natural repair and replacement of damaged cells and tissues. By doing so, they aim to promote healing for a wide range of health conditions and injuries.

Their flagship product, realSKIN™, represents a pioneering advancement in clinical xenotransplantation, offering a groundbreaking treatment for severe burns. As leaders in the field, XenoTherapeutics is dedicated to accelerating the testing, development, and availability of innovative live biotherapeutic products. Their ultimate goal is to ensure a steady and sufficient supply of these life-changing regenerative medicine solutions.

With a focus on addressing critical healthcare needs, XenoTherapeutics is committed to contributing to a healthier future for all. Experience the future of regenerative medicine with XenoTherapeutics